Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use authorization to market a ...

While COVID-19 never fully went away the way many of us hoped it would when we were embracing Zoom happy hours and worked from home in March of 2020, ramped-up testing efforts have made it easier to ...

BHV-1300 achieved deep lowering of targeted IgG, with reductions > 60% in the lowest subcutaneous dose tested in the MAD. Subcutaneous BHV-1300 achieved rapid and progressive lowering of IgG within ...

I recently saw a patient with 2 transient ischemic attack-like episodes of regional limb weakness and parasthesias lasting for short periods without sequelae. Testing revealed a moderately elevated ...

What do the moment you end up with a positive COVID-19 self-test, according to an epidemiologist and government officials. If you want to figure out your COVID-19 status in the comfort of your own ...

Optimized subcutaneous administration of BHV-1300 achieved rapid, deep and sustained lowering of IgG, differentiating Biohaven's new small molecule class of degraders from the monoclonal antibody FcRn ...

UPDATE (3/5/25) — The Oklahoma State Department of Health (OSDH) released additional information for the public on Wednesday after announcing there is no cases of measles in Oklahoma. OSDH said ...